GAO Adulteration Report Points To Disconnect Among FDA Offices
This article was originally published in The Tan Sheet
Executive Summary
Food and drug attorneys critique the Government Accountability Office’s report on FDA’s efforts to counter economically motivated adulteration, which calls for greater cross-agency collaboration.